Dr. Rajiv I Modi, CMD of Cadila Pharmaceuticals, said: “The lowering of GST rates on medicines and healthcare products will provide much-needed relief to patients. All drugs and medicines have now been prescribed a concessional GST rate of 5%. GST on various life-saving drugs and three critical drugs used for the treatment of cancer, rare diseases, and severe chronic conditions have been reduced from 5–12% to zero. The government has also prescribed a 5% rate for all medical devices and instruments used in medical, surgical, and dental practices. These measures will ease the financial burden on patients, improve access to life-saving treatment, and strengthen healthcare. At Cadila Pharmaceuticals, we remain committed to providing the highest quality medicines at the most affordable cost, ensuring accessibility to the last man in society.”
